South Wales, July 8 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "KNOTBODY" on June 19. The details about the trademark application no. UK00004221551 published in the journal no. 2025/027 (July 4).
With Stratagem Intellectual Property Management Limited as representative, Maxion Therapeutics Limited filed the trademark application for the below mentioned good(s)/service(s).
Class 1 : Chemicals for use in industry and science; biochemicals, including polypeptides and antibodies for scientific, laboratory or research purposes; polypeptides and antibodies for use in the manufacture of pharmaceuticals and drugs; ion channel modulating antibodies, including antagonists or agonists for scientific, laboratory or research purposes; ion channel modulating antibodies, including antagonists or agonists for use in the manufacture of pharmaceuticals and drugs; antibodies being antagonists or agonists for modulating G-protein-coupled receptors (GPCRs) for scientific, laboratory or research purposes; antibodies being antagonists or agonists for modulating G-protein-coupled receptors (GPCRs) for use in the manufacture of pharmaceuticals and drugs; antibodies derived from mini-protein toxins for scientific, laboratory or research purposes; antibodies derived from mini-protein toxins for use in the manufacture of pharmaceuticals and drugs. .
Class 5 : Pharmaceuticals and pharmaceutical preparations; drugs; antibodies for medical use; pharmaceuticals, drugs and pharmaceutical preparations incorporating antibodies, ion channel modulating antibodies including antagonists or agonists, antibodies being antagonists or agonists for modulating G-protein-coupled receptors (GPCRs) or antibodies derived from mini-protein toxins; vaccines.
Class 42 : Scientific and technological services and research and design relating thereto; drug discovery and drug development services; conducting or providing research and development services for others in the field of antibodies; laboratory services relating to the production of antibodies, ion channel modulating antibodies including antagonists or agonists, antibodies being antagonists or agonists for modulating G-protein-coupled receptors (GPCRs) or antibodies derived from mini-protein toxins; antibody engineering; scientific services relating to the discovery, preclinical and clinical development of therapeutic products; information, advisory and consultancy services in relation to all of the aforesaid; .
Class 44 : Medical services; medical testing, analysis and diagnostic services in the field of antibodies; medical services connected with the treatment of diseases through the use of antibodies, ion channel modulating antibodies including antagonists or agonists, antibodies being antagonists or agonists for modulating G-protein-coupled receptors (GPCRs) or antibodies derived from mini-protein toxins, or pharmaceuticals, drugs and pharmaceutical preparations derived from the aforesaid; information, advisory and consultancy services in relation to all of the aforesaid.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004221551
Disclaimer: Curated by HT Syndication.
